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Purpose of review  
Hematopoietic stem cells (HSCs) and progenitors are tasked with maintaining 
hematopoietic homeostasis in the face of numerous insults and challenges, including 
infection, inflammation and exsanguination. HSCs possess the remarkable ability to 
reconstitute the entire hematopoietic system of an organism whose own hematopoietic 
system has been ablated. This ability is exploited routinely in the clinic via HSC 
transplantation (HSCT). Here, we focus on the physiological and molecular bottlenecks 
overcome by HSCs during transplantation. 
 
Recent findings 
Upon transplantation, HSCs need to encounter a damaged bone marrow (BM) niche, 
characterized molecularly by increases in oxygen concentrations and an altered cytokine 
milieu. New mechanisms and pathways have been recently implicated during HSCT, 
including transplanted HSC-dependent secretion of conditioning molecules that facilitate 
engraftment and pathways that protect HSCs from perturbed organelle homeostasis. 
 
Summary  
Better understanding the molecular processes HSCs employ to withstand the stress of 
transplant will illuminate novel targets for further improving conditioning regimens and 
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HSCs are defined functionally by their ability to reconstitute hematopoiesis when 
transplanted into an organism whose own hematopoietic system has been ablated by 
irradiation, chemotherapy or disease. To preserve stemness and genome integrity, HSCs 
are quiescent and, in murine models, rarely divide during an individual’s lifetime unless 
challenged by insults that stimulate them to proliferate and differentiate (*1). To 
reconstitute an ablated hematopoietic system, transplanted HSCs must overcome many 
damaging insults, such as oxidative stress and migration through a bone marrow niche 
physically damaged by conditioning, resulting in metabolic changes and exit from 
quiescence in HSCs. Despite all this, HSCT is a clinical success and is employed >50,000 
times worldwide each year to treat hematologic disease and cancer patients (2). 
Unfortunately, still about one-third of autologous or allogeneic transplant recipients will 
die for reasons other than primary disease relapse, such as infection, organ failure and 
Graft vs. Host Disease (GvHD) (3). A greater understanding of the molecular bottlenecks 
that stifle HSC function could illuminate novel therapeutic targets to improve clinical 
HSCT outcomes. Here, we will focus on reviewing our current understanding of the 
physical and molecular bottlenecks HSC must overcome during transplant to achieve 






A damaged niche  
HSCT patients are usually pre-conditioned by chemotherapy and/or radiotherapy.  The 
HSC BM niche is complex and multifaceted, with adipocytes, endothelial cells, 
megakaryocytes, heterogeneous stromal cells, macrophages, osteoblasts, and sympathetic 
nerves all implicated as functional contributors during homeostasis (4, 5). Transplant pre-
conditioning disrupts some key components of the HSC BM niche, transforming it from a 
“BM homeostatic niche (h-Niche)” into what can be thought of as an acute “BM 
reconstituting niche (r-Niche)”. For example, although osteoblasts appear minimally 
perturbed by conditioning (4), the sinusoidal vascular network is severely disrupted, 
becomes leaky, displays changes in morphology and structure, and swells (Figure 1). 
Genetic alterations of BM vascular endothelium integrity negatively impact HSC 
function (6**), highlighting the importance of intact vasculature for HSCs. The damaged 
vasculature takes weeks to recover and donor-derived hematopoietic cells, via the 
VEGF/VEGFR2 axis, have been implicated as participants in its recovery (4, 7). Gross 
changes in the levels and locations of cytokines critical to the viability and distribution of 
HSCs, such as SDF-1 (the Stromal Cell Derived Factor-1; also known as CXC 
chemokine ligand 12, CXCL12), VEGF, IGF-1, PDGF-BB, and TPO, have also been 
observed after conditioning (4, 5, 8). Changing CXCL12 levels following irradiation and 
the break-down of the sinusoidal vasculature results in redistribution of BM 
megakaryocytes from sinusoidal vessels to the endosteal surface; contributing to the 
distinct architecture of the r-Niche (4, 5, 9). Indeed, megakaryocytes facilitate BM injury 
recovery by producing FGF, which also stimulates HSC proliferation via the FGFR and 
up-regulation of NFκB and CXCR4, (the CXCL12 receptor and a master regulator of 
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HSC trafficking and niche retention) (10) (Figure 1). Conditioning regimens are also 
toxic to the nervous system, especially in children (11). During homeostasis, Schwann 
cell-derived TGF supports the integrity of the HSC pool (12, 13). Damage to BM glia 
by conditioning could deregulate HSC stores. Conditioning also alters the BM 
extracellular matrix in ways that functionally feedback on HSCs. Irradiation induces 
endothelial E-SELECTIN production via NFκB activation and TENASCIN-C production 
by stromal cells and endothelium (14, 15) (Figure 1). Both of these molecules stimulate 
HSC homing, E-SELECTIN via E-SELECTIN-LIGAND-1 (ESL-1), which is expressed 
by HSCs, and TENASCIN C via INTEGRIN α9 (16). TENASCIN C/INTEGRIN α9 
engagement can trigger HSCs to enter the cell-cycle by up-regulating CyclinD1 and 
CyclinE1 and down-regulating cyclin-dependent kinase inhibitors (p57(Kip2), p21(Cip1), 
p16(Ink4a) (14).  
 
During inflammation or vascular damage, adenosine triphosphate (ATP), uridine 
triphosphate (UTP) and possibly other nucleotides are released into the extracellular 
environment (17). Most blood cells respond to nucleotides via purinergic P2 receptors 
(17). P2Y14 is highly expressed by both human and mouse HSPCs (18*, 19). P2y14-/- 
HSCs display hyper-radiosensitivity due to their inability to regulate ROS levels that 
accumulate and induce senescence through p38 hyper-activation (19). Moreover, 
knockdown of P2y14 in murine HSC comprises their engraftment (18*). These data 
suggest that P2Y14, and potentially additional purinergic receptors, might function as 
critical sensors of tissue damage by detecting elevated nucleotides in the r-Niche and 
promoting HSC survival by controlling increasing ROS levels post-transplant (Figure 1).  
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These studies and others establish that the r-Niche is physically and molecularly distinct 
from the h-Niche (20). Moreover, they suggest that the recovery of the r-Niche, and 
successful HSC engraftment, depends, in part, on transplanted hematopoietic cells, 
including HSPCs.  
 
Functional HSC must home to the reconstituting niche (r-Niche) 
To effectively reconstitute hematopoiesis, transplanted HSCs must both find their way to 
the BM and stably establish themselves within the r-Niche. HSC BM homing following 
transplant is rapid (hours to 1-2 days) and requires rolling, anchorage to the BM 
sinusoids, trans-endothelial migration and stable interaction with niche components (8, 
21). CXCL12 is critically required for HSC migration from the fetal liver to the BM 
during embryogenesis (22). Antibody blocking of CXCR4 (by AMD-3100) or elevated 
CXCL12 plasma levels can mobilize HSPCs from the BM to the periphery (13, 23). 
CXCL12 is critical for BM HSC homing during transplant, where it is expressed by 
osteoblasts and endothelium  (4, 24, 25). CXCL12 levels increase in the r-Niche after 
conditioning, which attracts HSCs and facilitates their stable engraftment (4, 8) (Figure 
1). Since many BM proteinases, such as Matrix Metalloproteinases 2/9 (MMP2 and 
MMP9), can cleave CXCL12 and negatively affect its activity as a chemo-attractant, it 
would be of interest to study their levels in a r-Niche. Modulating the activity of these 
proteinases could benefit current HSCT protocols  (21, 26). Other chemo-attractants have 
also been implicated in directing the migration and mobilization of HSCs, including 
CCL2, CCL5, CXCL10, IL-8, SCF, LTD4, sphingosin-1-phosphate and ceramide-1 
phosphate (21, 26-29).  
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Notably, conditioning by irradiation or cyclophosphamide results in elevated cleavage of 
COMPLEMENT COMPONENT3 (C3) into C3a and iC3b in PB and BM (30). HSC 
express C3aR and CR3 (also known as CD11b/CD18 or Mac-1), which are receptors for 
C3 cleavage fragments (30). C3a sensitizes human and mouse HSCs to CXCL12 
gradients by promoting CXCR4 incorporation into membrane lipid rafts, while iC3b 
deposited on damaged BM stroma increases HSC adhesion to niche components via 
interaction with CR3 (30) (Figure 1). Importantly, C3-/- mice are more sensitive to G-CSF 
mobilization (30). Although these mice have normal steady-state hematopoiesis, they 
display a delay in hematopoietic recovery when subjected to sub-lethal irradiation or 
HSC transplantation. C3-/- HSCs function normally when transplanted into C3+/+ 
recipients, indicating that this phenotype results from a defect in the BM niche (30). 
Thus, cleaved C3 is important for BM regeneration and reconstitution following 
conditioning and may be an essential component of the r-Niche (30). 
 
Both mouse and human HSC have also been shown to express multiple molecules that 
critically regulate their ability to physically engage r-Niche cells (such as the sinusoidal 
endothelium).  For example, blocking or genetic loss of integrins, such as 4, 91, 
and 47, inhibit robust HSC engraftment (21, 31, 32). HSC rolling on the endothelium, 
necessary for extravasation into the BM space, is regulated by interactions with 
endothelial P and L-SECTININs (33). Antibody blocking of CD44 also blocks HSC 
engraftment (34). More recently, CYTOHESIN-1 and JAM-B/JAM-C interactions have 
also been implicated in HSC niche engagement (35, 36), as have factors that likely 
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regulate to the ability to HSCs to physically move through the vasculature and BM, such 
as ARHGEF5, a Rho guanine nucleotide exchange factor important for podosome 
formation (37) (Figure 1). Not surprisingly, knockdown of Arhgef5 in murine HSPCs 
significantly impairs their transplantation (18*). Further, conditioning regimens can 
impact how HSC physically engage the r-Niche. For example, BM endothelium up-
regulates MAdCAM-1, an 4 ligand, in response to total body irradiation (31).  
Blocking MAdCAM-1 in this context is highly detrimental to HSC engraftment (31). 
 
HSC-directed niche conditioning facilitates engraftment  
Evidence is accumulating that transplanted HSCs can themselves act on the r-Niche in 
ways that promote their own engraftment (Figure 1). For example, knockdown of 
secreted factors or molecules that regulate the biogenesis of secreted factors (e.g. Fstl1, 
Crispld1) in mouse HSPCs reduces their transplantation (18*). Although the mechanisms 
here are unknown, FSTL1 is a negative regulator BMP signaling that has been implicated 
in vasculature remodeling and ischemic cardiomyocyte regeneration (38, 39). HSCs 
express putative “niche-conditioning” molecules implicated in HSC quiescence, such as 
RNase ANGIOGENIN, IL-8 and EMBIGEN (40**). HSCs also express ESL-1, a 
regulator of HSC proliferative homeostasis via repression of TGF production by HSCs 
and other hematopoietic cells. ESL-1-deficient HSCs produce more TGFβ, which 
conditions the niche to induce quiescence in wild type co-transplanted HSCs (41*). 
Degrading enzymes, such as MMPs, are important for efficient HSC homing (8). Up-
regulation of MMP-2, MMP-9 and MT1-MMP facilitates HSCT and BM homing by 
promoting extravasation via degradation of extra-cellular matrix components, enhancing 
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migration towards CXCL12, and by releasing soluble Kit ligand from BM stroma (42). 
As mentioned, transplanted hematopoietic cells promote vasculature recovery after severe 
irradiation (43).  Conversely, transplanted hematopoietic cells can also negatively 
influence r-Niche recovery: donor-derived angiopoietin-1 (ANGPT-1) slows vasculature 
recovery after irradiation, likely by negatively regulating endothelial cell proliferation 
(7). Thus, a better understanding of the reciprocal interactions between incoming HSCs 
and the r-Niche could illuminate novel strategies for improving engraftment. 
 
Oxidative stress and changing metabolic needs 
Steady-state HSCs are largely quiescent, depend on glycolysis for energy production, 
and, consequently, display low levels of radical oxygen species (ROS) (44-*46). The h-
Niche is irrigated with a heterogeneous network of arterioles, which carry 
oxygenated blood and are most abundant near the endosteum, and sinusoids, which 
carry less oxygenated blood and are abundant in the central BM (20, 47-49). This 
creates an oxygen gradient in the BM, from ≈4% O2 near the endosteum to ≈2% in 
the central marrow (50, 51). However, the distribution of HSCs throughout the BM 
suggests that HSC maintain a hypoxic profile regardless of their location and 
external O2 tension (24, 47, 48, 50-52). Although it is formally possible that super-
low O2 levels might exist in tight regions proximal to HSCs (50).  
 
Transplant pre-conditioning, and the resulting cell damage, elevates BM O2 levels 
(51) (Figure 1). Transplanted HSPCs distribute throughout this landscape of elevated 
oxygen (51). Under low oxygen, HIF-1 is active and transcriptionally promotes 
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glycolysis. As O2 levels rise, HIF-1 is targeted for degradation, promoting a shift in 
HSC metabolism from glycolysis to oxidative phosphorylation (OXPHOS), which further 
increases internal ROS levels (44, 45). Increased ROS impairs HSC self-renewal, 
quiescence, and promotes their mobilization from the bone marrow (53, 54). Indeed, 
purified ROSLow HSCs display superior repopulating activity relative to ROSHigh HSCs 
(44). HSCs also become exposed to supra-physiologic levels of oxygen during their 
isolation and handling prior to transplant (55**). Inhibition of ROS accumulation by anti-
oxidants such as N-acetyl-L-cysteine (NAC) or via manipulation of signaling pathways 
linked to ROS accumulation (p38 MAPK, the miR-212/132 cluster (Mirc19) or SIRT3 
overexpression) rescues HSC function and transplantation (54, 56-58). Thus, HSC must 
engage molecular pathways to resolve these insults in order to achieve stable engraftment 
and hematopoietic repopulation. Indeed, a failure to transition from glycolysis into 
OXPHOS blocks HSC differentiation (59, **60), indicating that is required for effective 
hematopoietic reconstitution. Further, constitutive mTOR activation, a master sensor of 
cellular metabolic needs, is detrimental to HSC quiescence and serial repopulation, which 
appears to be in part explained by elevated ROS (61, 62). Moreover, the PML-PPARδ 
pathway for fatty acid oxidation regulates asymmetric versus symmetric HSC division 
and disruption of this pathway leads HSC exhaustion (53). 
 
SIRT1, a deacetylase that globally coordinates metabolic changes in response to nutrient 
levels, is also required for optimal HSC transplantation (63). SIRT1 functions upstream 
of FOXO3 in HSCs to modulate changing intracellular ROS levels (**60, 63) (Figure 1). 
Indeed, FOXO factors are well known critical regulators of HSC ROS, both during 
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homeostasis and transplantation (**60, 64). While FoxO-deficient bone marrow lacks 
long-term engraftment, in vivo treatment with NAC reverts this phenotype (65). 
Similarly, Foxa3-/- HSCs display high ROS post-transplant and compromised serial 
transplantation (18*). A SIRT1-related enzyme, SIRT3, is also required for optimal HSC 
transplantation, but only in aged HSC (58). SIRT3 regulates the acetylation of 
mitochondrial proteins (65). Thus, to effectively repopulate, transplanted HSCs must 
affect a balance between their shifting metabolic needs and the detrimental effects of 
elevated ROS on their self-renewal and differentiation. 
 
Epigenetic regulators 
Recently, several studies have illuminated single cell heterogeneity within the HSC pool 
and suggested a model where HSC function is transplantable and imprinted by specific 
epigenetic patterns, such as DNA methylation, hydroxymethylation, and histone 
modification (66, *67, 68). Transplantation may perturb the HSC epigenetic landscape. 
For example, as HSCs switch from glycolysis to OXPHOS during transplant, increasing 
α-ketoglutarate and decreasing succinate may activate histone demethylases and trigger 
differentiation (65). The compromised differentiation potential, enhanced self-renewal, 
and sensitization to apoptosis of HSC deficient in Dnmt1 or Dnmt3a demonstrates that 
DNA methylation levels can significantly impact HSC function (69, 70). Active DNA de-
methylation also perturbs HSC transplantation. TET family proteins hydroxylate 5-
methylcytosine to 5-hydroxymethylcytosine, which is then deaminated by AID/APOBEC 
proteins before processed into cytosine by BER glycosylases. Tet2-/- mice display 
increased HSC numbers and increased HSC repopulating activity (71). In contrast, Aid-/- 
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mice display expansion of myeloid cells and anemia due to reduced erythroid 
progenitors, but display normal HSC self-renewal (72). Histone modification patterns 
also appear important for HSC transplantation. Loss of EED, which methylates H3K27 as 
part of the Polycomb Repressive Complex 2, results in HSC exhaustion (66, 73). In 
contrast, Ezh2 overexpression perpetuates HSC serial transplantation (74). HSCs also 
display bivalent domains that contain H3K4me3 and H3K27me3 (75). To what extent the 
epigenetic landscape of HSC is altered by transplantation remains an open question. 
 
Transplant challenges organelle homeostasis  
Recent data suggests that transplanted HSCs must cope with perturbations in organelle 
homeostasis. For example, the essential autophagy gene, Atg7, is required for HSC 
repopulation (76). Further, as transplanted HSC exit quiescence and increase oxidative 
phosphorylation, mitochondria numbers increase (44, 55**, 77). This activates 
mitochondrial pathways regulating oxidative stress, such as SIRT1, a deacetylase that 
targets FOXO transcription factors in HSCs (**60). Loss of SIRT7, a regulator of the 
mitochondrial unfolded protein response, result in reduced repopulating activity, 
reflecting the dependence of transplanted HSCs on this pathway (**78).  
 
Oxidative stress, accumulating mis-folded proteins, or calcium disequilibrium can induce 
endoplasmic reticulum (ER) stress (79). Glucose-regulated protein 78 (GPR78), an ER 
chaperone, regulates and inactivates multiple ER stress sensors (80). Gpr78-deficient 
mice show a loss in HSCs (81). The ER unfolded protein response (UPR) is resolved by 
inhibition of translation, activation of ubiquitin-dependent degradation of mis-folded 
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proteins or by increased ER biogenesis (79). Indeed, overexpression of ERDJ4 (a 
canonical UPR chaperone) in human HSCs enhances their repopulating activity, 
indicating that ERDJ4 protects against transplant-induced ER stress (82) (Figure 1). 
Further, human HSPCs display higher expression of PERK pathway members and 




Classic pre-transplant conditioning triggers a plethora of cellular responses that 
cumulatively select for the small population of bone marrow cells we know as 
transplantable HSCs. These cellular responses likely exist to counteract environmental 
insults to the hematopoietic system (e.g. infection, exsanguination, starvation, etc…) by 
allowing HSC division and activation while safeguarding genome integrity and stemness. 
Although the molecular mechanisms behind many of these responses have been recently 
illuminated, we are still far from fully understanding HSC engraftment. Indeed, numerous 
novel alternative conditioning methods reveal that HSCT does not depend on complete 
bone marrow ablation (e.g. dietary Valine depletion, anti-c-Kit or CD45 antibodies, 
CD45-saporin, inhibition of stromal cell heparan sulfate synthesis and E-SELECTIN 
antagonists (**83,84). These new methods hold the promise of alleviating the non-
hematopoietic toxicity associated with classic conditioning regimens, which will be 
especially important for children and young adults. Further, each likely imposes unique 
molecular pressures on transplanted HSCs. Further study of these alternative conditioning 
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• Transplant conditioning regimens induce dramatic changes in the HSC bone 
marrow niche. 
• Transplanted HSCs are subject to significant metabolic changes, perturbed 
organelle homeostasis, and elevated ROS levels. 
• HSCs autonomously condition their new home to facilitate engraftment. 
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Figure 1. Summary of molecular alterations driven by classical pre-transplant 
conditioning regimens in HSCs and the bone marrow niche 
 
Here, we present a schematic to highlight some of the gross physical and molecular 
changes that occur in the bone marrow niche and within HSCs. For simplicity, not every 
known cellular component of the niche is pictured. In the niche, C3 is cleaved to C3b and 
C3a, which interact with HSC CR3 and C3aR receptors and stimulate homing by 
increasing, among other things, CXCR4. Megakaryocytes, which are attracted to the 
endosteum from sinusoidal vessels by increasing endosteal-CXCL12, also upregulate 
CXCR4 on HSCs via increased secretion of FGF. Schwann cells and stromal cells release 
TENASCIN C, which stimulates HSC migration and adhesion. Endothelial cells 
upregulate E-SELECTIN, CXCL12 and SCF. Sinusoidal vessels are damaged and leaky, 
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resulting in an increase in O2 partial pressure (p02) and BM ROS levels. This contributes 
to H1F-1α degradation in HSCs, promoting their transition from glycolysis to oxidative 
respiration (OXPHOS), which further increases intracellular ROS levels. FOXOs, 
FOXA3, and signaling downstream of P2Y14 help HSCs cope with rising ROS levels. 
SIRT1 activates FOXOs. SIRT7 inhibits the increase in the mitochondrial unfolded 
protein response (UPR). Increased ROS stimulates HSC division and an ER-UPR. PERK 
and ERDJ14 counteract this effect in transplanted HSCs. Free nucleotide levels rise in the 
BM and are sensed by purinergic receptors, like P2Y14, which regulates ROS. Increasing 
intracellular α-Ketoglutarate (α-KG) promotes HSC differentiation via Histone 
demethylation (Figure 1). PRC2 complex counteracts this effect by promoting Histone 
methylation. Transplanted HSCs condition the reconstituting niche by secreting FSTL1 
and extracellular matrix components (via Crispld1) and (very likely) additional factors 
(e.g. IL-8) (Figure 1). Transplanted hematopoietic cells facilitate recovery of the 
conditioned niche. Figure Key: the bone marrow space is depicted on a dark gray 
background, the HSC intracellular space is light gray, and the HSC nucleus is dark gray. 
Major cell types are labeled in white font, major changes in the bone marrow space are 
labeled in white font, and major changes in the HSC are labeled in black font.  
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